News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Steven Frank: Phase III Level I evidence for proton therapy in head and neck malignancies to be presented at ASCO
Photo from Steven Frank/X
May 29, 2024, 09:13

Steven Frank: Phase III Level I evidence for proton therapy in head and neck malignancies to be presented at ASCO

Steven Frank, Executive Director of Particle Therapy Institute at MD Anderson Cancer Center, shared on X:

“Congratulations to all participating institutions for driving Phase III Level I evidence for proton therapy in head and neck malignancies to be presented at ASCO on June 4th.”         .

View additional information.
Source: Steven Frank/X

ASCO24 cancer head and neck malignancies OncoDaily Oncology proton therapy Steven Frank The University of Texas MD Anderson Cancer Center
Special Coverage
Blog
Nov 2, 2024, 03:14
Ruben Mesa: Celebrating New Professors at Wake Forest University School of Medicine
Blog
Nov 2, 2024, 03:06
In the new episode of Lung Cancer Considered, host Stephen Liu previews the upcoming HTTR24 - IASLC
Blog
Nov 2, 2024, 03:04
Melvin LK Chua: Potential Increased Risks of Toxicities with Combo IO Immunotherapy and RT
Blog
Nov 2, 2024, 03:01
Dimitra R. Bakaloudi: Sometimes the secret to success is simply finding your why
Blog
Nov 2, 2024, 02:53
Emily June Zolfaghari: Learned so much about lung cancer screening initiatives at Rescue Lung Society
Blog
Nov 2, 2024, 02:43
Robin Zon: Driving Knowledge to Action - Building a Better Future
Blog
Nov 2, 2024, 02:38
Ting Bao: Presenting our Integrative Medicine for chemotherapy-induced peripheral neuropathy
Insight
Nov 2, 2024, 02:35
Carmine Valenza: ICIs in patients with metastatic TN-IBC
Blog
Nov 2, 2024, 02:31
Jason Westin: Advocacy is a year round opportunity to fight for our patients
Insight
Nov 2, 2024, 02:19
Nico Gagelmann: Remarkable and forgotten women in the history of medicine and science
Insight
Nov 2, 2024, 02:08
INAVO120: Inavolisib with Palbociclib–Fulvestrant Doubles PFS in PIK3CA-Mutated Breast Cancer
Blog
Nov 1, 2024, 20:27
Amy Oxentenko: Honored to be inducted as President of the American College of Gastroenterology